User:Mr. Ibrahem/Bivalirudin

Bivalirudin, sold under the brand names Angiomax and Angiox, is a medication used during percutaneous coronary intervention (PCI). It can be used in people with heparin-induced thrombocytopenia (HIT). It is given by injection into a vein.

Common side effects include bleeding. Safety in pregnancy is unclear. It is a direct thrombin inhibitor (DTI) and a manufactured version of hirudin.

Bivalirudin was approved for medical use in the United States in 2000. While it was approved in Europe in 2004, this approval was subsequently withdrawn. It is available as a generic medication. In the United States 250 mg costs about 115 USD as of 2022.